SCHEMBL4309124

SCHEMBL4309124

COc1c(OCC(=O)O)ccc(C=Cc2n[nH]c3ccccc23)c1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.45
MEN1 O00255 8/20 0.45
KMT2A Q03164 8/20 0.45
LMNA P02545 7/20 0.45
ALDH1A1 P00352 5/20 0.45
NPC1 O15118 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
GAA P10253 4/20 0.45
HTT P42858 3/20 0.45
RAB9A P51151 3/20 0.45
POLB P06746 3/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
CTNNB1 P35222 1/20 0.39
WNT3A P56704 1/20 0.39
STAT3 P40763 1/20 0.38
HIF1A Q16665 1/20 0.38
CTSD P07339 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4309120 1.00 MAPT (0.45) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4308261 0.87 MAPT (0.41) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4308256 0.87 MAPT (0.41) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4311757 0.87 MAPT (0.60) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4314023 0.86 TP53 (0.42) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4314012 0.86 TP53 (0.42) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4314957 0.85 ALDH1A1 (0.42) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4314967 0.85 ALDH1A1 (0.42) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4321984 0.84 MAPT (0.41) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL4321978 0.84 MAPT (0.41) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 MAPT 4175/4885MEN1 1830/4885KMT2A 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.